NFKB1 and cancer: Overall, this non-exhaustive list of examples highlights how NF-κB deregulation in cancer is extremely diversified, being the result of interactions of many players at many levels: mutations can occur in NF-κB proteins or in their target genes, either in the regulatory or in the coding sequences.